News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,633 Results
Type
Article (87064)
Company Profile (704)
Press Release (767850)
Multimedia
Podcasts (156)
Webinars (21)
Section
Business (232910)
Career Advice (4134)
Deals (39771)
Drug Delivery (131)
Drug Development (91151)
Employer Resources (200)
FDA (18216)
Job Trends (17376)
News (397032)
Policy (39861)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (125)
Alzheimer's disease (1620)
Antibody-drug conjugate (ADC) (194)
Approvals (18187)
Artificial intelligence (421)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (109)
Brain cancer (44)
Breast cancer (416)
Cancer (3297)
Cardiovascular disease (263)
Career advice (3544)
Career pathing (34)
CAR-T (218)
CDC (43)
Cell therapy (603)
Cervical cancer (26)
Clinical research (74610)
Collaboration (1185)
Company closure (4)
Compensation (792)
Complete response letters (42)
COVID-19 (2920)
CRISPR (71)
C-suite (419)
Cystic fibrosis (126)
Data (3371)
Decentralized trials (2)
Denatured (56)
Depression (85)
Diabetes (391)
Diagnostics (7012)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (196)
Drug pricing (163)
Drug shortages (36)
Duchenne muscular dystrophy (171)
Earnings (98516)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (131753)
Executive appointments (933)
FDA (20273)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1060)
Gene editing (154)
Generative AI (42)
Gene therapy (476)
GLP-1 (964)
Government (5310)
Grass and pollen (7)
Guidances (323)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (198)
Immuno-oncology (16)
Indications (43)
Infectious disease (3127)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (142)
Interviews (813)
IPO (17911)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (63)
Layoffs (612)
Leadership (27)
Legal (10141)
Liver cancer (87)
Longevity (12)
Lung cancer (458)
Lymphoma (234)
Machine learning (16)
Management (65)
Manufacturing (502)
MASH (107)
Medical device (14779)
Medtech (14791)
Mergers & acquisitions (22638)
Metabolic disorders (1003)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2440)
NextGen: Class of 2025 (7687)
Non-profit (5092)
Now hiring (52)
Obesity (508)
Opinion (298)
Ovarian cancer (108)
Pain (136)
Pancreatic cancer (136)
Parkinson's disease (209)
Partnered (26)
Patents (354)
Patient recruitment (209)
Peanut (55)
People (65869)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23010)
Phase II (32387)
Phase III (24399)
Pipeline (2243)
Policy (264)
Postmarket research (3554)
Preclinical (10397)
Press Release (72)
Prostate cancer (161)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (557)
Real estate (7404)
Recruiting (76)
Regulatory (27417)
Reports (63)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (111)
Series A (176)
Series B (128)
Service/supplier (30)
Sickle cell disease (70)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (77)
The Weekly (98)
Vaccines (959)
Venture capital (62)
Weight loss (347)
Women's health (53)
Worklife (20)
Date
Today (159)
Last 7 days (694)
Last 30 days (2696)
Last 365 days (33876)
2025 (21172)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (287)
Arkansas (14)
Asia (50646)
Australia (8897)
California (8380)
Canada (2556)
China (765)
Colorado (358)
Connecticut (374)
Delaware (225)
Europe (116292)
Florida (1256)
Georgia (285)
Hawaii (3)
Idaho (67)
Illinois (767)
India (36)
Indiana (408)
Iowa (19)
Japan (251)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (75)
Maryland (1167)
Massachusetts (6371)
Michigan (286)
Minnesota (519)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (92)
New Hampshire (75)
New Jersey (2321)
New Mexico (31)
New York (2310)
North Carolina (1298)
North Dakota (10)
Northern California (3679)
Ohio (268)
Oklahoma (17)
Oregon (48)
Pennsylvania (1785)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (39)
South Dakota (1)
Southern California (3145)
Tennessee (136)
Texas (1299)
United States (31384)
Utah (246)
Virginia (228)
Washington D.C. (80)
Washington State (725)
West Virginia (4)
Wisconsin (89)
There are 855,633 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Precigen Wins First FDA Immunotherapy Nod for Recurrent Respiratory Papillomatosis
Papzimeos is the first immunotherapy approved for recurrent respiratory papillomatosis, a rare lung disorder involving the development of benign tumors in the airways.
August 15, 2025
·
1 min read
·
Tristan Manalac
Vaccines
Kennedy Revives Childhood Vaccines Safety Group, Led by NIH’s Bhattacharya
The move comes after Robert F. Kennedy Jr. received pressure from the Children’s Health Defense, an anti-vaccine non-profit that he co-founded, which last month sued him over his failure to run the “statutorily required Task Force on childhood vaccine,” according to the lawsuit.
August 15, 2025
·
2 min read
·
Tristan Manalac
Vaccines
After Scrapping mRNA Contracts, Kennedy Says mRNA Vaccines ‘May Be Very Effective’ for Cancer
The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according to Secretary Robert F. Kennedy Jr.
August 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
August 15, 2025
·
2 min read
Press Releases
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
August 15, 2025
·
11 min read
Press Releases
Novel Gene Therapy for ALS cleared for global trials in China and the U.S.
August 15, 2025
·
4 min read
Press Releases
Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
August 15, 2025
·
14 min read
Press Releases
Santhera extends Highbridge convertible bond to 30th September 2025
August 15, 2025
·
2 min read
Press Releases
BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth.
August 15, 2025
·
6 min read
Press Releases
Vistin Pharma ASA: Second quarter and YTD 2025 financial results
August 15, 2025
·
1 min read
1 of 85,564
Next
